<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab4">
 <label>Table 4</label>
 <caption>
  <p>Factors associated with pretreatment HIV drug resistance among HIV-infected individuals initiating ART in 2017 in China</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Variable</th>
    <th>Number</th>
    <th>PDR, N (%)</th>
    <th>
     <italic>OR</italic> (95% 
     <italic>CI</italic>)
    </th>
    <th>
     <italic>P</italic>-value
    </th>
    <th>a
     <italic>OR</italic> (95% 
     <italic>CI</italic>)
    </th>
    <th>
     <italic>P</italic>-value
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Total</td>
    <td>1711</td>
    <td>117 (6.8)</td>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">Age (years)</td>
   </tr>
   <tr>
    <td>  &lt; 25</td>
    <td>209</td>
    <td>16 (7.7)</td>
    <td>1.00</td>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  ≥ 25</td>
    <td>1502</td>
    <td>101 (6.7)</td>
    <td>0.87 (0.50–1.51)</td>
    <td>0.62</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">Sex</td>
   </tr>
   <tr>
    <td> Male</td>
    <td>1301</td>
    <td>93 (7.2)</td>
    <td>1.00</td>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Female</td>
    <td>410</td>
    <td>24 (5.9)</td>
    <td>0.76 (0.48–1.22)</td>
    <td>0.26</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">Marital status</td>
   </tr>
   <tr>
    <td> Unmarried</td>
    <td>562</td>
    <td>38 (6.8)</td>
    <td>1.00</td>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Married</td>
    <td>873</td>
    <td>59 (6.8)</td>
    <td>1.00 (0.66–1.53)</td>
    <td>0.99</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Divorce or widow</td>
    <td>271</td>
    <td>20 (7.4)</td>
    <td>1.10 (0.63–1.93)</td>
    <td>0.74</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Unknown</td>
    <td>5</td>
    <td>0 (0.0)</td>
    <td>-</td>
    <td>0.99</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">Education</td>
   </tr>
   <tr>
    <td> Primary and below</td>
    <td>638</td>
    <td>52 (8.2)</td>
    <td>1.00</td>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Junior high school</td>
    <td>496</td>
    <td>35 (7.1)</td>
    <td>0.86 (0.55–1.34)</td>
    <td>0.49</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Senior high school</td>
    <td>217</td>
    <td>14 (6.5)</td>
    <td>0.78 (0.42–1.43)</td>
    <td>0.42</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> College</td>
    <td>307</td>
    <td>15 (4.9)</td>
    <td>0.58 (0.32–1.05)</td>
    <td>0.07</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Unknown</td>
    <td>53</td>
    <td>1 (1.9)</td>
    <td>0.22 (0.03–1.60)</td>
    <td>0.13</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">Route of infection</td>
   </tr>
   <tr>
    <td> Heterosexual intercourse</td>
    <td>1027</td>
    <td>57 (5.6)</td>
    <td>1.00</td>
    <td/>
    <td>1.00</td>
    <td/>
   </tr>
   <tr>
    <td> Homosexual intercourse</td>
    <td>453</td>
    <td>27 (6.0)</td>
    <td>1.08 (0.67–1.73)</td>
    <td>0.75</td>
    <td>1.48 (0.87–2.52)</td>
    <td char="." align="char">0.15</td>
   </tr>
   <tr>
    <td> Intravenous drug use</td>
    <td>160</td>
    <td>28 (17.5)</td>
    <td>3.61 (2.22–5.88)</td>
    <td>&lt; 0.001</td>
    <td>2.64 (1.57–4.44)</td>
    <td char="." align="char">&lt; 0.001</td>
   </tr>
   <tr>
    <td> Others</td>
    <td>71</td>
    <td>5 (7.0)</td>
    <td>1.29 (0.50–3.33)</td>
    <td>0.60</td>
    <td>1.56 (0.60–4.08)</td>
    <td char="." align="char">0.36</td>
   </tr>
   <tr>
    <td colspan="7">CD4 count before ART (cells/mm
     <sup>3</sup>)
    </td>
   </tr>
   <tr>
    <td>  &lt; 350</td>
    <td>1076</td>
    <td>71 (6.6)</td>
    <td>1.00</td>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  ≥ 350</td>
    <td>576</td>
    <td>45 (7.8)</td>
    <td>1.20(0.81–1.77)</td>
    <td>0.36</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Missing</td>
    <td>59</td>
    <td>1 (1.7)</td>
    <td>0.24(0.03–1.79)</td>
    <td>0.17</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">Subtype</td>
   </tr>
   <tr>
    <td> CRF01_AE</td>
    <td>559</td>
    <td>26 (4.7)</td>
    <td>1.00</td>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> CRF07_BC</td>
    <td>633</td>
    <td>49 (7.7)</td>
    <td>1.72 (1.05–2.81)</td>
    <td>0.03</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> CRF08_BC</td>
    <td>228</td>
    <td>19 (8.3)</td>
    <td>1.86 (1.01–3.44)</td>
    <td>0.05</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> CRF55_01B</td>
    <td>64</td>
    <td>8 (12.5)</td>
    <td>2.93 (1.27–6.78)</td>
    <td>0.01</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> B</td>
    <td>40</td>
    <td>1 (2.5)</td>
    <td>0.53 (0.07–3.98)</td>
    <td>0.53</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> C</td>
    <td>53</td>
    <td>5 (9.4)</td>
    <td>2.14 (0.78–5.81)</td>
    <td>0.14</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Others</td>
    <td>134</td>
    <td>9 (6.7)</td>
    <td>1.48 (0.68–3.23)</td>
    <td>0.33</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">Region</td>
   </tr>
   <tr>
    <td> Others</td>
    <td>1124</td>
    <td>55 (4.9)</td>
    <td>1.00</td>
    <td/>
    <td>1.00</td>
    <td/>
   </tr>
   <tr>
    <td> Liangshan, Dehong and Lincang
     <sup>a</sup>
    </td>
    <td>587</td>
    <td>62 (10.6)</td>
    <td>2.30 (1.57–3.35)</td>
    <td>&lt; 0.001</td>
    <td>2.04 (1.26–3.30)</td>
    <td char="." align="char">0.004</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup>: The HIV epidemic was the most severe in Liangshan, Dehong and Lincang. The HIVDR rate was high in these areas
  </p>
  <p>
   <italic>PDR</italic> pretreatment drug resistance, 
   <italic>OR</italic> odds ratio, a
   <italic>OR</italic> adjusted odds ratio, 
   <italic>CI</italic> confidence interval, 
   <italic>ART</italic> antiretroviral therapy, 
   <italic>HIV</italic> Human immunodeficiency virus, 
   <italic>HIVDR</italic> HIV drug resistance; -: Not applicable.
  </p>
 </table-wrap-foot>
</table-wrap>
